Lansoprazole promotes cisplatin‐induced acute kidney injury via enhancing tubular necroptosis

Acute kidney injury (AKI) is the main obstacle that limits the use of cisplatin in cancer treatment. Proton pump inhibitors (PPIs), the most commonly used class of medications for gastrointestinal complications in cancer patients, have been reported to cause adverse renal events. However, the effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cell Mol Med
Main Authors: Ye, Lin, Pang, Wanxia, Huang, Yanheng, Wu, Hongluan, Huang, Xiaorong, Liu, Jianxing, Wang, Shujun, Yang, Chen, Pan, Qingjun, Liu, Huafeng
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933939/
https://ncbi.nlm.nih.gov/pubmed/33605079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16302
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados